ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M04A Antigout preparations edit
M04AA Preparations inhibiting uric acid production edit
- M04AA01 Allopurinol
- M04AA02 Tisopurine
- M04AA03 Febuxostat
- M04AA51 Allopurinol, combinations
M04AB Preparations increasing uric acid excretion edit
- M04AB01 Probenecid
- M04AB02 Sulfinpyrazone
- M04AB03 Benzbromarone
- M04AB04 Isobromindione
- M04AB05 Lesinurad
M04AC Preparations with no effect on uric acid metabolism edit
- M04AC01 Colchicine
- M04AC02 Cinchophen
- M04AC51 Colchicine and probenecid
M04AX Other antigout preparations edit
- M04AX01 Urate oxidase
- M04AX02 Pegloticase
References edit
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.